{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_7yBZ8gIeh1j","type":"doc","o":"1","documentId":"ucms_7yBZ8gIeh1j"},"body":{"newStatus":"1","documentId":"ucms_7yBZ8gIeh1j","staticId":"ucms_7yBZ8gIeh1j","title":"贵州三力:拟取得汉方药业、德昌祥药业不超51%股权","shareTitle":"贵州三力:拟取得汉方药业、德昌祥药业不超51%股权","thumbnail_doc":"","thumbnail":"","source":"证券时报","author":"","editorcode":"weMedia","editTime":"2020-07-17 19:18:23","updateTime":"2020\/07\/17 19:18:23","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/7yBZ8gIeh1j","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/7yBZ8gIeh1j","commentsUrl":"ucms_7yBZ8gIeh1j","commentCount":0,"text":"
证券时报e公司讯,贵州三力(603439)7月17日晚间公告,公司拟通过现金方式向贵州汉方药业有限公司、贵阳德昌祥药业有限公司增资,取得汉方药业、德昌祥药业不超过51%的股权。初步测算,此次交易可能构成重大资产重组。<\/p>","img":[],"summary":"证券时报e公司讯,贵州三力(603439)7月17日晚间公告,公司拟通过现金方式向贵州汉方药业有限公司、贵阳德昌祥药业有限公司增资,取得汉方药业、德昌祥药业不超","sharesummary":"证券时报e公司讯,贵州三力(603439)7月17日晚间公告,公司拟通过现金方式向贵州汉方药业有限公司、贵阳德昌祥药业有限公司增资,取得汉方药业、德昌祥药业不超","commentType":"0","wemediaEAccountId":"706","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002dKXIspBK9zhTHGiKvzg3qrn1RwvP4mqX0t0n4pjhFns__","praise":"0","like_num":"0"}}